XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Merger and Related Transactions - Additional Information (Details)
$ / shares in Units, $ in Millions
9 Months Ended
Mar. 17, 2023
$ / shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
Dec. 31, 2023
$ / shares
Mar. 31, 2023
$ / shares
Business Acquisition [Line Items]          
Stock issued during period private placement | shares   0.0288      
Consideration Transferred   $ 29.4      
Prepaid and other current assets obtained   2.1      
Payables and accruals incurred   2.3      
Transaction costs   $ 4.6      
Common stock par value | $ / shares   $ 0.0001   $ 0.0001  
Severance and termination benefit expense   $ 5.7      
Acceleration of stock awards   $ 10.5      
Common Stock          
Business Acquisition [Line Items]          
Shares issued during period upon conversion of units | shares   3,946,540      
CalciMedica          
Business Acquisition [Line Items]          
Percentage of ownership of common stock   72.00%      
Graybug          
Business Acquisition [Line Items]          
Percentage of ownership of common stock   28.00%      
Graybug          
Business Acquisition [Line Items]          
Number of shares of stock issued | shares   1,571,433      
Common stock par value | $ / shares $ 0.0001       $ 0.0001
Reverse Stock Split 14        
Acceleration of stock awards     $ 10.5